Evidence map›Paper›PMID 30656537›Full record

ArticleJournal of robotic surgery2019

Therapeutic supine robotic retroperitoneal lymph node dissection for post-chemotherapy residual masses in testicular cancer: technique and outcome analysis of initial experience.

Ashwin Sunil Tamhankar, Saurabh Ramesh Patil, Surya Prakash Ojha, Puneet Ahluwalia, Gagan Gautam

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of robotic surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ashwin Sunil TamhankarMax Institute of Cancer Care, New Delhi, India.
Saurabh Ramesh PatilMax Institute of Cancer Care, New Delhi, India.
Surya Prakash OjhaMax Institute of Cancer Care, New Delhi, India.
Puneet AhluwaliaMax Institute of Cancer Care, New Delhi, India.
Gagan GautamMax Institute of Cancer Care, New Delhi, India. gagangg@gmail.com.ORCID http://orcid.org/0000-0002-3106-706X
Max Healthcare · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retroperitoneal lymph node dissection (RPLND) is a therapeutic standard of care for post-chemotherapy residual masses in testicular cancer. While a robotic approach to this procedure has the potential of decreasing the morbidity associated with this major endeavour, it is often criticised for its inability to provide a bilateral complete template resection without redocking and repositioning the patient. Herein, we present the technique and initial outcomes of a supine approach to Robotic RPLND (R-RPLND) using the da Vinci Xi

Indexed as

AdultAntineoplastic AgentsHumansLymph Node ExcisionMalePatient PositioningPostoperative ComplicationsRetroperitoneal SpaceRobotic Surgical ProceduresSupine PositionTesticular NeoplasmsTestisTreatment OutcomeYoung AdultAntineoplastic AgentsDa Vinci Xi® systemPost-chemotherapy residual masses in testicular cancerRetroperitoneal lymph node dissectionRobotic RPLND

Identifiers

PMID30656537
OpenAlexW2909481233

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.